SwiftPharma

Karel Van De Woestijnestraat 6

9000 Gent

BE

SwiftPharma

Foundation date

04/02/2022

Sector

#Biotechnology - other

Subsector

Development of recombinant biologics using plants as mini-bioreactors. Our technology combines speed, agility, scalability, safety, and low-cost production completely animal-free

Upcoming events

News by SwiftPharma

  • SwiftPharma and PlantForm target blockbuster cancer drug with new contract manufacturing agreement for plant-made biosimilars

    Tuesday November 14th 2023

  • SwiftPharma launches ODIN.AI: A groundbreaking AI-augmented antibody discovery platform

    Monday October 9th 2023

  • SwiftPharma and Medace sign strategic collaboration agreement for biomanufacturing and purification of promising medicinal proteins.

    Wednesday September 27th 2023